2023-07-012024-06-302024-06-30false08623707AUTISM TREATMENT PLUS LIMITED2024-08-1586900iso4217:GBPxbrli:pure086237072023-07-01086237072024-06-30086237072023-07-012024-06-30086237072022-07-01086237072023-06-30086237072022-07-012023-06-3008623707bus:SmallEntities2023-07-012024-06-3008623707bus:AuditExempt-NoAccountantsReport2023-07-012024-06-3008623707bus:AbridgedAccounts2023-07-012024-06-3008623707bus:PrivateLimitedCompanyLtd2023-07-012024-06-3008623707core:WithinOneYear2024-06-3008623707core:AfterOneYear2024-06-3008623707core:WithinOneYear2023-06-3008623707core:AfterOneYear2023-06-3008623707core:ShareCapital2024-06-3008623707core:SharePremium2024-06-3008623707core:RevaluationReserve2024-06-3008623707core:OtherReservesSubtotal2024-06-3008623707core:RetainedEarningsAccumulatedLosses2024-06-3008623707core:ShareCapital2023-06-3008623707core:SharePremium2023-06-3008623707core:RevaluationReserve2023-06-3008623707core:OtherReservesSubtotal2023-06-3008623707core:RetainedEarningsAccumulatedLosses2023-06-3008623707core:LandBuildings2024-06-3008623707core:PlantMachinery2024-06-3008623707core:Vehicles2024-06-3008623707core:FurnitureFittings2024-06-3008623707core:OfficeEquipment2024-06-3008623707core:NetGoodwill2024-06-3008623707core:IntangibleAssetsOtherThanGoodwill2024-06-3008623707core:ListedExchangeTraded2024-06-3008623707core:UnlistedNon-exchangeTraded2024-06-3008623707core:LandBuildings2023-06-3008623707core:PlantMachinery2023-06-3008623707core:Vehicles2023-06-3008623707core:FurnitureFittings2023-06-3008623707core:OfficeEquipment2023-06-3008623707core:NetGoodwill2023-06-3008623707core:IntangibleAssetsOtherThanGoodwill2023-06-3008623707core:ListedExchangeTraded2023-06-3008623707core:UnlistedNon-exchangeTraded2023-06-3008623707core:LandBuildings2023-07-012024-06-3008623707core:PlantMachinery2023-07-012024-06-3008623707core:Vehicles2023-07-012024-06-3008623707core:FurnitureFittings2023-07-012024-06-3008623707core:OfficeEquipment2023-07-012024-06-3008623707core:NetGoodwill2023-07-012024-06-3008623707core:IntangibleAssetsOtherThanGoodwill2023-07-012024-06-3008623707core:ListedExchangeTraded2023-07-012024-06-3008623707core:UnlistedNon-exchangeTraded2023-07-012024-06-3008623707core:MoreThanFiveYears2023-07-012024-06-3008623707core:Non-currentFinancialInstruments2024-06-3008623707core:Non-currentFinancialInstruments2023-06-3008623707dpl:CostSales2023-07-012024-06-3008623707dpl:DistributionCosts2023-07-012024-06-3008623707core:LandBuildings2023-07-012024-06-3008623707core:PlantMachinery2023-07-012024-06-3008623707core:Vehicles2023-07-012024-06-3008623707core:FurnitureFittings2023-07-012024-06-3008623707core:OfficeEquipment2023-07-012024-06-3008623707dpl:AdministrativeExpenses2023-07-012024-06-3008623707core:NetGoodwill2023-07-012024-06-3008623707core:IntangibleAssetsOtherThanGoodwill2023-07-012024-06-3008623707dpl:GroupUndertakings2023-07-012024-06-3008623707dpl:ParticipatingInterests2023-07-012024-06-3008623707dpl:GroupUndertakingscore:ListedExchangeTraded2023-07-012024-06-3008623707core:ListedExchangeTraded2023-07-012024-06-3008623707dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2023-07-012024-06-3008623707core:UnlistedNon-exchangeTraded2023-07-012024-06-3008623707dpl:CostSales2022-07-012023-06-3008623707dpl:DistributionCosts2022-07-012023-06-3008623707core:LandBuildings2022-07-012023-06-3008623707core:PlantMachinery2022-07-012023-06-3008623707core:Vehicles2022-07-012023-06-3008623707core:FurnitureFittings2022-07-012023-06-3008623707core:OfficeEquipment2022-07-012023-06-3008623707dpl:AdministrativeExpenses2022-07-012023-06-3008623707core:NetGoodwill2022-07-012023-06-3008623707core:IntangibleAssetsOtherThanGoodwill2022-07-012023-06-3008623707dpl:GroupUndertakings2022-07-012023-06-3008623707dpl:ParticipatingInterests2022-07-012023-06-3008623707dpl:GroupUndertakingscore:ListedExchangeTraded2022-07-012023-06-3008623707core:ListedExchangeTraded2022-07-012023-06-3008623707dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2022-07-012023-06-3008623707core:UnlistedNon-exchangeTraded2022-07-012023-06-3008623707core:NetGoodwill2024-06-3008623707core:IntangibleAssetsOtherThanGoodwill2024-06-3008623707core:LandBuildings2024-06-3008623707core:PlantMachinery2024-06-3008623707core:Vehicles2024-06-3008623707core:FurnitureFittings2024-06-3008623707core:OfficeEquipment2024-06-3008623707core:AfterOneYear2024-06-3008623707core:WithinOneYear2024-06-3008623707core:ListedExchangeTraded2024-06-3008623707core:UnlistedNon-exchangeTraded2024-06-3008623707core:ShareCapital2024-06-3008623707core:SharePremium2024-06-3008623707core:RevaluationReserve2024-06-3008623707core:OtherReservesSubtotal2024-06-3008623707core:RetainedEarningsAccumulatedLosses2024-06-3008623707core:NetGoodwill2023-06-3008623707core:IntangibleAssetsOtherThanGoodwill2023-06-3008623707core:LandBuildings2023-06-3008623707core:PlantMachinery2023-06-3008623707core:Vehicles2023-06-3008623707core:FurnitureFittings2023-06-3008623707core:OfficeEquipment2023-06-3008623707core:AfterOneYear2023-06-3008623707core:WithinOneYear2023-06-3008623707core:ListedExchangeTraded2023-06-3008623707core:UnlistedNon-exchangeTraded2023-06-3008623707core:ShareCapital2023-06-3008623707core:SharePremium2023-06-3008623707core:RevaluationReserve2023-06-3008623707core:OtherReservesSubtotal2023-06-3008623707core:RetainedEarningsAccumulatedLosses2023-06-3008623707core:NetGoodwill2022-07-0108623707core:IntangibleAssetsOtherThanGoodwill2022-07-0108623707core:LandBuildings2022-07-0108623707core:PlantMachinery2022-07-0108623707core:Vehicles2022-07-0108623707core:FurnitureFittings2022-07-0108623707core:OfficeEquipment2022-07-0108623707core:AfterOneYear2022-07-0108623707core:WithinOneYear2022-07-0108623707core:ListedExchangeTraded2022-07-0108623707core:UnlistedNon-exchangeTraded2022-07-0108623707core:ShareCapital2022-07-0108623707core:SharePremium2022-07-0108623707core:RevaluationReserve2022-07-0108623707core:OtherReservesSubtotal2022-07-0108623707core:RetainedEarningsAccumulatedLosses2022-07-0108623707core:AfterOneYear2023-07-012024-06-3008623707core:WithinOneYear2023-07-012024-06-3008623707core:Non-currentFinancialInstrumentscore:CostValuation2023-07-012024-06-3008623707core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-07-012024-06-3008623707core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-07-012024-06-3008623707core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-07-012024-06-3008623707core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-07-012024-06-3008623707core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-07-012024-06-3008623707core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-07-012024-06-3008623707core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-07-012024-06-3008623707core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-07-012024-06-3008623707core:Non-currentFinancialInstrumentscore:CostValuation2024-06-3008623707core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-06-3008623707core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-06-3008623707core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-06-3008623707core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-06-3008623707core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-06-3008623707core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-06-3008623707core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-06-3008623707core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-06-3008623707core:Non-currentFinancialInstrumentscore:CostValuation2023-06-3008623707core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-06-3008623707core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-06-3008623707core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-06-3008623707core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-06-3008623707core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-06-3008623707core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-06-3008623707core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-06-3008623707core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-06-3008623707bus:Director12023-07-012024-06-30086237071bus:Director12023-07-01086237071bus:Director12023-07-012024-06-30086237071bus:Director12024-06-30086237072023-07-01086237072023-07-012024-06-30086237072024-06-30

AUTISM TREATMENT PLUS LIMITED

Registered Number
08623707
(England and Wales)

Unaudited Financial Statements for the Year ended
30 June 2024

AUTISM TREATMENT PLUS LIMITED
Company Information
for the year from 1 July 2023 to 30 June 2024

Director

AMET, Lorene Eve Aurelie, Dr

Registered Address

3rd Floor
207 Regent Street
London
W1B 3HH

Registered Number

08623707 (England and Wales)
AUTISM TREATMENT PLUS LIMITED
Balance Sheet as at
30 June 2024

Notes

2024

2023

£

£

£

£

Current assets
Debtors2,610878
Cash at bank and on hand11,7409,352
14,35010,230
Creditors amounts falling due within one year(5,068)(3,218)
Net current assets (liabilities)9,2827,012
Total assets less current liabilities9,2827,012
Net assets9,2827,012
Capital and reserves
Called up share capital11
Profit and loss account9,2817,011
Shareholders' funds9,2827,012
The financial statements were approved and authorised for issue by the Director on 15 August 2024, and are signed on its behalf by:
AMET, Lorene Eve Aurelie, Dr
Director
Registered Company No. 08623707
AUTISM TREATMENT PLUS LIMITED
Notes to the Financial Statements
for the year ended 30 June 2024

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
The financial statements have been prepared in accordance with the Companies Act 2006 and FRS 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland including Section 1A Small Entities.
Revenue from sale of goods
Revenue from the sale of goods is recognised when the company has transferred to the buyer the significant risks and rewards of ownership of the goods, usually when goods are delivered and legal title has passed. Providing the amount of revenue can be measured reliably, it is probable that the economic benefits associated with the transaction will flow to the company and the costs incurred or to be incurred in respect of the transition can be measured reliably.
2.Average number of employees

20242023
Average number of employees during the year11
3.Directors advances, credits and guarantees

Brought forward

Amount advanced

Amount repaid

Carried forward

££££
AMET, Lorene Eve Aurelie, Dr2,4161,25703,673
2,4161,25703,673